News

Search:

OIG: Oversight of Drug, Device, Clinical Trial Safety One of Their ‘Top Challenges’

0 Likes

The Office of the Inspector General (OIG) of the US Department of Health and Human Services is calling the “oversight of the approval, safety and marketing of drugs and devices” one of their “top [Read More...]

Tags:

Challenges

FDA

OIG

report

New Regulatory Focus Apps for iPad and iPhone

Most Viewed
Most Popular

Most Viewed

France: New Agency to Soon Replace AFSSAPS 1 May 2012
Obama Signs Order Promoting International Regulatory Cooperation 1 May 2012
Choosing the Right Regulatory Career: An Inside Look 17 February 2012
FDA Releases Long-Awaited Guidances on Biosimilar Price Competition and Innovation Act 9 February 2012
FDA Provides New Guidance for Promotional Labeling and Advertising 25 January 2012
RAPS Scope of Practice Study: Tracking the Regulatory Profession 22 February 2012
UPDATED: EMA, AFSSAPS Call for Stricter EU Regulations on Medical Devices 6 January 2012
FDA: 99% of Establishment Registrations Now Electronic Post-FDAAA 13 January 2012

Stay Connected:

Regulatory Focus is for regulatory professionals written by regulatory professionals.

The publication takes a look at the important topics facing regulatory professionals in a changing global healthcare landscape. From topics ranging from research and development to labeling and marketing, the articles try to analyze, inform, and educate readers about the issues at the forefront of the industry.

Rated as the number one benefit by the members of RAPS, Regulatory Focus strives to provide the best and most current information to regulatory professionals so they can succeed and advance at every stage in their careers.

For questions or comments on our content or to find out more about Regulatory Focus, please visit our About RF page.